These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28878052)

  • 21. Clinical assessment of olfactory dysfunction in Parkinson's disease.
    Potagas C; Dellatolas G; Ziegler M; Leveteau J; Bathien N; Mac Leod P; Rondot P
    Mov Disord; 1998 May; 13(3):394-9. PubMed ID: 9613727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The course of olfactory deficits in patients with Parkinson's disease--a study based on psychophysical and electrophysiological measures.
    Meusel T; Westermann B; Fuhr P; Hummel T; Welge-Lüssen A
    Neurosci Lett; 2010 Dec; 486(3):166-70. PubMed ID: 20858529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olfactory deficit in Alzheimer's disease?
    Doty RL
    Am J Psychiatry; 2001 Sep; 158(9):1533-4; author reply 1534-5. PubMed ID: 11532759
    [No Abstract]   [Full Text] [Related]  

  • 24. Animal models of olfactory dysfunction in neurodegenerative diseases.
    Prediger RD; Schamne MG; Sampaio TB; Moreira ELG; Rial D
    Handb Clin Neurol; 2019; 164():431-452. PubMed ID: 31604561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of subjective olfaction ratings in patients with and without olfactory disorders.
    Haxel BR; Bertz-Duffy S; Fruth K; Letzel S; Mann WJ; Muttray A
    J Laryngol Otol; 2012 Jul; 126(7):692-7. PubMed ID: 22588245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A clinical approach towards smell loss in Parkinson's disease.
    Haehner A; Hummel T; Reichmann H
    J Parkinsons Dis; 2014; 4(2):189-95. PubMed ID: 24322062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.
    Siderowf A; Stern MB
    Ann Neurol; 2008 Dec; 64 Suppl 2():S139-47. PubMed ID: 19127581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensor Array for Detection of Early Stage Parkinson's Disease before Medication.
    Finberg JPM; Schwartz M; Jeries R; Badarny S; Nakhleh MK; Abu Daoud E; Ayubkhanov Y; Aboud-Hawa M; Broza YY; Haick H
    ACS Chem Neurosci; 2018 Nov; 9(11):2548-2553. PubMed ID: 29989795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Olfaction and olfactory disorders].
    Hummel T
    HNO; 2014 Dec; 62(12):845. PubMed ID: 25323732
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progress in clinical studies on olfaction: olfactory tests].
    Miwa T; Shiga H; Tsukaya T; Furukawa M
    Nihon Jibiinkoka Gakkai Kaiho; 2008 May; 111(5):399-404. PubMed ID: 18595208
    [No Abstract]   [Full Text] [Related]  

  • 31. Olfactory dysfunction in the pathophysiological continuum of dementia.
    Bathini P; Brai E; Auber LA
    Ageing Res Rev; 2019 Nov; 55():100956. PubMed ID: 31479764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostics of olfactory disorders in the patients with Parkinson's disease and polypous sinusitis with the use of the Sniffin' Sticks test].
    Alekseeva NS; Ponomareva TA
    Vestn Otorinolaringol; 2014; (1):37-40. PubMed ID: 24577030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anosmia and Ageusia in Parkinson's Disease.
    Tarakad A; Jankovic J
    Int Rev Neurobiol; 2017; 133():541-556. PubMed ID: 28802932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and the premotor phase of Parkinson disease.
    Tolosa E; Gaig C; Santamaría J; Compta Y
    Neurology; 2009 Feb; 72(7 Suppl):S12-20. PubMed ID: 19221308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory dysfunction as a predictor of neurodegenerative disease.
    Albers MW; Tabert MH; Devanand DP
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):379-86. PubMed ID: 16928347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical (premotor) Parkinson's disease.
    Wolters EC; Francot C; Bergmans P; Winogrodzka A; Booij J; Berendse HW; Stoof JC
    J Neurol; 2000 Apr; 247 Suppl 2():II103-9. PubMed ID: 10991655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of a three-item smell identification test in detecting olfactory dysfunction.
    Jackman AH; Doty RL
    Laryngoscope; 2005 Dec; 115(12):2209-12. PubMed ID: 16369168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of smell test identification in Parkinson's disease in Mexico: a matched case-control study.
    Rodríguez-Violante M; Lees AJ; Cervantes-Arriaga A; Corona T; Silveira-Moriyama L
    Mov Disord; 2011 Jan; 26(1):173-6. PubMed ID: 20842690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
    Postuma RB; Gagnon JF; Vendette M; Montplaisir JY
    Brain; 2009 Dec; 132(Pt 12):3298-307. PubMed ID: 19843648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different odor tests contribute differently to the evaluation of olfactory loss.
    Lötsch J; Reichmann H; Hummel T
    Chem Senses; 2008 Jan; 33(1):17-21. PubMed ID: 17761724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.